Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO)

NCT05216757 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Hand Osteoarthritis
Inflammatory Arthritis

Interventions

DRUG: Iguratimod
DRUG: placebo

Sponsor

Peking University People's Hospital